Global Cord Blood Corporation (CORBF)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Ting Zheng | CEO & CEO of Beijing Division | 516.68k | -- | 1972 |
| Mr. Bing Chuen Chen C.F.A. | Chief Financial Officer | 516.68k | -- | 1976 |
| Ms. Xin Xu | Chief Technology Officer | 122.78k | -- | 1954 |
| Ms. Rui Arashiyama | Chief Executive Officer of Guangdong & Zhejiang Divisions | 257.5k | -- | 1959 |
| Ms. Cathy Bai | Vice President of Corporate Finance | -- | -- | -- |
Global Cord Blood Corporation
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 1,202
Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 9, 2024 at 12:00 AM UTC
NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F